Tirzepatide demonstrated that adding GIP activation to GLP-1 agonism produced meaningfully better outcomes than GLP-1 alone
Geniposide, acting as a GLP-1R agonist, partially prevented STZ-induced learning and memory impairment via modulation of PI3K/GSK-3 signaling pathway and reduced STZ-induced hyperphosphorylation of tau protein (220)
After 40 weeks, all three tirzepatide groups lost 4-12 more pounds, on average, than the semaglutide group and came out with healthier diabetic biomarkers.3 Another example is a massive cohort study of 18,386 patients, which found that tirzepatide patients lost 5-15% more weight than their semaglutide counterparts.4 Tirzepatides superior efficacy correlates with a higher cost compared to semaglutide
What to keep in mind: The $149/month covers the Wegovy pill cost
The specification table on this page covers identity, formula, molecular mass, physical form, solubility, storage, and lot-level analytical information
The economic picture of Retatrutide for extended use is more accessible than the current pharmaceutical alternatives for many people in Canada who dont have comprehensive drug coverage